NCT03889899View on ClinicalTrials.gov

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2026

Conditions
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Interventions
DEVICE

Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)

An intratumoral insertion of a seed(s), loaded with Radium-224, securely fixed in the seeds. The seeds release by recoil into the tumor short-lived alpha-emitting atoms.

Trial Locations (1)

3109601

RECRUITING

RAMBAM Health Care Campus, Haifa

Sponsors
All Listed Sponsors
lead

Alpha Tau Medical LTD.

INDUSTRY